폴리카프로락톤 실리카 나노 복합체를 이용한 골이식대체재 개발에 관한 연구
Study on the development of polycaprolacton silica nanohybrid for bone substitutes
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
A bioactive and degradable poly(epsilon -caprolactone)/silica nanohybrid(PSH) was synthesized for the application as a bone substitute. PSH was manufactured by using silica and polycaprolacton. PSH was manufactured in some composition after low crystaline apatite had been formed in simulated body fluid and, was used this study. The safety of the PSH was established by test of acute, and subacute toxicity, sensitization cytotoxicity and sterility. In order to assess activity of osteoblast, the test for attaching osteoblast, proliferation test for osteoblast, differentiating gene expression test are performed in vitro. And bone substitutes were grafted in rabbit's calvarium, during 8 weeks for testing efficacy of bone substitutes. Degree of osteogenesis and absorption of substitutes were evaluated in microscopic level. In result, it was not appeared that acute and subacute toxicity, sensitization in intradermal induction phase, topical induction phase and challenge phase. It was shown that the test can not inhibit cell proliferation. adversely, it had some ability to accelerate cell proliferation. The result of sterility test described bacterial growth was not detected in most test tube. The attaching and proliferation test of osteoblast had good results. In the result of differentiating gene expression test for osteoblast, cbfa1 and, alkaline phosphatase, osteocalcin and GAPDH were detected with mRNA analysis. In the PSH bone formation test, ostgeoblastic activity would be different as material constitution but it had good new bone formation ability except group #218. futhermore, some material had been absorbed within 8 weeks. Above studies, PSH had bio-compatibility with human body, new bone formation ability and accelerate osteoblastic activity. So it would be the efficient bone substitute material with bio-active and biodegradable.
참고문헌 (31)
- "Tissue engineering : the first decade and beyond", pp.30, 297~31 ,303 (1998)
- "Release of bioactive human growth hormone from a biodegradable material: poly (epsilon -caprolactone)", 40(2), pp.204~213 (1998)
- "Bone Tissue Engineering", 1, pp.1322~1324 (1995)
- "Synthesis and characterization of polycaprolactone", poly( ethylene oxide), pp.1999, 10(4)[DOI]
- "Analysis of a biodegradable composite for bone healing", 32(3), pp.419~424 (1996)
- "In vitro evaluation of biodegradable varepsilon-caprolactone-co-D, L-lactide", silica xerogel composites containing toremifene citrate, 1999, pp.30, 181~191
- "Induction of bioactivity of a non-bioactive glass-ceramic by a chemical treatment", 18(22), pp.1479~1485 (1997)
- "In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials", 23(15), pp.3113~3122 (2002)
- "A new injectable bone substitute combining poly(epsilon-caprolactone) microparticles with biphasic calcium phosphate granules", 22(20), pp.2785~2794 (2001)
- "A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications", 11, pp.667~678 (1996)
- "A novel degradable polycaprolactone networks for tissue engineering", 24(5), pp.801~808 (2003)
- "Poly (D,L-lactide", epsilon- caprolactone), pp.2000, 21[DOI]
- "Accelerated degradation of poly", pp.1030~4 (1994)
- "The mechanism of degradation for the absorbable biomaterials poly(epsilon-caprolactone) in vitro and in vivo", 14(4), pp.334~337 (1997)
- "Preparation of a bioactive and degradable poly", silica hybrid through a sol-gel method, 2002, pp.23(24), 4915~4921
- "Effect of molecular weight of poly( varepsilon -caprolactone) on interpenetrating network structure, apatite-forming ability, and degradability of poly( varepsilon -caprolac- tone)", silica nano-hybrid materials, 2003, pp.24(10), 1721~1727
- "In vitro evaluation of poly(epsilon-caprolactone-co-DL-lactide)", bioactive glass composites, 2002, pp.23(10), 2143~2150
- "Effects of ions in aqueous media on hydroxyapatite induction by silica gel and its relevance to bioactivity of bioactive glasses and glass-ceramics", pp.221~9 (1993)
- "Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly (DL-lactide-epsilon- caprolactone)", 5(36), pp.337~346 (1997)
- "Initial bone matrix formation at the hydroxyapatite interface in nitro", 29(1), pp.89~99 (1995)
- "Calcium phosphate ceramics as hard tissue prosthetics", 157, pp.259~278 (1981)
- "Retrospective analysis of hydroxyapatite development for oral implant applications", 36(1), pp.19~26 (1992)
- "Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics", 37, pp.122~129 (1997)
- "A review of current technology and applications", pp.187~201 (1991)
- "Different Forms of Bone Grafts", pp.6~8
- "Orthopaedic applications of hydroxyapatite", pp.171~12 178 (1991)
- "의료용구의 생물학적 안전에 관한 공통기준규격", (13) (2000)
- "Enhancing effect of poly on the differentiation of mouse osteoblast-like MC3T3-E1 cells Biomaterials", 24(19), pp.3303~3309 (2003)
- "생체분해성 폴리머", 칼슘포스페이트결정 콤포지트 인공기질내로의 세포이주에 관한 연구, 2000, pp.27(1), 75~81
- "In vivo investigations on composites made of resorbable ceramics and poly used as bone graft substitutes", 58(6), pp.701~709 (2001)
- "Evaluation of a tissue-engineered membrane-cell construct for guided bone regeneration", 17(2), pp.161~174 (2002)